Literature DB >> 25432098

Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy.

Laura Camoni1, Mariangela Raimondo, Maria Dorrucci, Vincenza Regine, Maria Cristina Salfa, Barbara Suligoi.   

Abstract

In 2012, we conducted a retrospective cross-sectional study to assess the number of people living with HIV linked to care and, among these, the number of people on antiretroviral therapy. The health authority in each of the 20 Italian Regions provided the list of Public Infectious Diseases Clinics providing antiretroviral therapy and monitoring people with HIV infection. We asked every Public Infectious Diseases Clinic to report the number of HIV-positive people diagnosed and linked to care and the number of those on antiretroviral therapy during 2012. In 2012, 94,146 people diagnosed with HIV and linked to care were reported. The majority were males (70.1%), Italians (84.4%), and aged between 25 and 49 years (63.4%); the probable route of transmission was heterosexual contact in 37.5% of cases, injecting drug use in 28.1%, and male-to-male contact in 27.9%. Among people in care, 20.1% had less than 350 CD4 cells/μl, 87.6% received antiretroviral therapy, and among these, 62.4% had a CD4 cell count higher than 350 cells/μl. The overall estimated prevalence of individuals diagnosed and linked to care in 2012 in Italy was 0.16 per 100 residents (all ages). Adding the estimated proportion of undiagnosed people, the estimated HIV prevalence would range between 0.19 and 0.26 per 100 residents. In Italy, the majority of people diagnosed and linked to care receive antiretroviral therapy. A higher prevalence of individuals diagnosed and linked to care was observed in Northern Italy and among males. More information for developing the HIV care continuum is necessary to improve the entire engagement in care, focusing on test-and-treat strategies to substantially reduce the proportion of people still undiagnosed or with a detectable viral load.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25432098      PMCID: PMC4348082          DOI: 10.1089/AID.2014.0154

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  20 in total

1.  Prevalence and characteristics of individuals with undiagnosed HIV infection in France: evidence from a survey on hepatitis B and C seroprevalence.

Authors:  Françoise Cazein; Francis Barin; Yann Le Strat; Josiane Pillonel; Stephane Le Vu; Florence Lot; Damien Thierry; Christine Meffre; Caroline Semaille
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

2.  A survey of HIV care in the UK: results of British HIV association (BHIVA) national audit 2010.

Authors:  S Ellis; H Curtis; Elc Ong
Journal:  Int J STD AIDS       Date:  2013-06-14       Impact factor: 1.359

3.  Few Italian drug users undergo HIV testing.

Authors:  L Camoni; B Federico; G Capelli; V Regine; M C Salfa; G Nicoletti; P Canuzzi; N Magliocchetti; G Rezza; B Suligoi
Journal:  AIDS Behav       Date:  2011-05

4.  "Test and treat": is it enough?

Authors:  Joep M A Lange
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

5.  High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.

Authors:  Julia C Dombrowski; Mari M Kitahata; Stephen E Van Rompaey; Heidi M Crane; Michael J Mugavero; Joseph J Eron; Stephen L Boswell; Benigno Rodriguez; W Christopher Mathews; Jeffrey N Martin; Richard D Moore; Matthew R Golden
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

6.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

7.  Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006.

Authors:  Michael L Campsmith; Philip H Rhodes; H Irene Hall; Timothy A Green
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

8.  Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.

Authors:  H Irene Hall; Emma L Frazier; Philip Rhodes; David R Holtgrave; Carolyn Furlow-Parmley; Tian Tang; Kristen Mahle Gray; Stacy M Cohen; Jonathan Mermin; Jacek Skarbinski
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

9.  Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS.

Authors:  Vincent C Marconi; Greg Grandits; Jason F Okulicz; Glenn Wortmann; Anuradha Ganesan; Nancy Crum-Cianflone; Michael Polis; Michael Landrum; Matthew J Dolan; Sunil K Ahuja; Brian Agan; Hemant Kulkarni
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

10.  Late presenters among persons with a new HIV diagnosis in Italy, 2010-2011.

Authors:  Laura Camoni; Mariangela Raimondo; Vincenza Regine; Maria Cristina Salfa; Barbara Suligoi
Journal:  BMC Public Health       Date:  2013-03-27       Impact factor: 3.295

View more
  8 in total

1.  Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study.

Authors:  Enrico Grande; Antonella Zucchetto; Barbara Suligoi; Francesco Grippo; Marilena Pappagallo; Saverio Virdone; Laura Camoni; Martina Taborelli; Vincenza Regine; Diego Serraino; Luisa Frova
Journal:  Popul Health Metr       Date:  2017-05-18

2.  The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges.

Authors:  Annabelle Gourlay; Teymur Noori; Anastasia Pharris; Maria Axelsson; Dominique Costagliola; Susan Cowan; Sara Croxford; Antonella d'Arminio Monforte; Julia Del Amo; Valerie Delpech; Asunción Díaz; Enrico Girardi; Barbara Gunsenheimer-Bartmeyer; Victoria Hernando; Sophie Jose; Gisela Leierer; Georgios Nikolopoulos; Niels Obel; Eline Op de Coul; Dimitra Paraskeva; Peter Reiss; Caroline Sabin; André Sasse; Daniela Schmid; Anders Sonnerborg; Alexander Spina; Barbara Suligoi; Virginie Supervie; Giota Touloumi; Dominique Van Beckhoven; Ard van Sighem; Georgia Vourli; Robert Zangerle; Kholoud Porter
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

3.  Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades.

Authors:  Jacob Levi; Alice Raymond; Anton Pozniak; Pietro Vernazza; Philipp Kohler; Andrew Hill
Journal:  BMJ Glob Health       Date:  2016-09-15

4.  Continuum of care among HIV-1 positive patients in a single center in Italy (2007-2017).

Authors:  Filippo Lagi; Seble Tekle Kiros; Irene Campolmi; Susanna Giachè; Pier Giorgio Rogasi; Marcello Mazzetti; Filippo Bartalesi; Michele Trotta; Patrizia Nizzoli; Alessandro Bartoloni; Gaetana Sterrantino
Journal:  Patient Prefer Adherence       Date:  2018-11-30       Impact factor: 2.711

5.  People living with undiagnosed HIV infection and a low CD4 count: estimates from surveillance data, Italy, 2012 to 2014.

Authors:  Vincenza Regine; Maria Dorrucci; Patrizio Pezzotti; Alessia Mammone; Chantal Quinten; Anastasia Pharris; Barbara Suligoi
Journal:  Euro Surveill       Date:  2018-04

6.  Is it Safe and Cost Saving to Defer the CD4+ Cell Count Monitoring in Stable Patients on Art with More than 350 or 500 cells/μl?

Authors:  Benedetto Maurizio Celesia; Andrea Marino; Rosa Fontana Del Vecchio; Roberto Bruno; Filippo Palermo; Maria Gussio; Giuseppe Nunnari; Bruno Cacopardo
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-11-01       Impact factor: 2.576

7.  How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data.

Authors:  Alessia Mammone; Patrizio Pezzotti; Vincenza Regine; Laura Camoni; Vincenzo Puro; Giuseppe Ippolito; Barbara Suligoi; Enrico Girardi
Journal:  AIDS       Date:  2016-04-24       Impact factor: 4.177

8.  Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region.

Authors:  Simona Cammarota; Anna Citarella; Lamberto Manzoli; Maria Elena Flacco; Giustino Parruti
Journal:  Clinicoecon Outcomes Res       Date:  2018-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.